Top compounds associated with response to ZNF345


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 1e-08
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 3e-08
mRNA barasertib CTRPv2 pan-cancer AAC 0.18 3e-08
mRNA WZ3105 GDSC1000 pan-cancer AAC 0.17 3e-08
mRNA pac-1 CTRPv2 pan-cancer AAC 0.2 4e-08
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 6e-08
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 9e-08
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA decitabine CTRPv2 pan-cancer AAC 0.14 4e-07
mRNA ML239 CTRPv2 pan-cancer AAC 0.18 7e-07
Download CSV